We are live on ! Find out more
B

Bailard Portfolio holdings

AUM $4.35B
1-Year Est. Return 23.57%
This Fund
S&P 500
This Quarter Est. Return
+6.04%
1 Year Est. Return
+23.57%
3 Year Est. Return
+74.84%
5 Year Est. Return
+96.64%
10 Year Est. Return
+374.16%
AUM
$3.84B
AUM Growth
+$211M
Cap. Flow
+$27.3M
Cap. Flow %
0.71%
Top 10 Hldgs %
28.65%
Holding
836
New
114
Increased
240
Reduced
234
Closed
102

Sector Composition

Rank Sector Weight
1 Technology 22.17%
2 Healthcare 8.13%
3 Financials 7.13%
4 Communication Services 5.05%
5 Consumer Discretionary 4.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RGR icon
701
Sturm, Ruger & Co
RGR
$607M
$213K 0.01%
5,100
CADE
702
DELISTED
Cadence Bank
CADE
$212K 0.01%
+6,641
New +$206K
MDV
703
Modiv Industrial
MDV
$183M
$211K 0.01%
12,587
+2,070
+20% +$31.8K
CMA
704
DELISTED
Comerica
CMA
$210K 0.01%
+3,500
New +$193K
OSBC icon
705
Old Second Bancorp
OSBC
$1.21B
$209K 0.01%
+13,400
New +$216K
BA icon
706
Boeing
BA
$165B
$208K 0.01%
1,371
-4,247
-76% -$728K
PBH icon
707
Prestige Consumer Healthcare
PBH
$2.32B
$208K 0.01%
2,885
-215
-7% -$15.2K
MGY icon
708
Magnolia Oil & Gas
MGY
$6.1B
$208K 0.01%
8,500
CIX icon
709
Comp X International
CIX
$319M
$207K 0.01%
+7,100
New +$188K
ASB icon
710
Associated Banc-Corp
ASB
$5.72B
$207K 0.01%
9,600
HCA icon
711
HCA Healthcare
HCA
$83.5B
$206K 0.01%
+508
New +$186K
LMT icon
712
Lockheed Martin
LMT
$131B
$203K 0.01%
+347
New +$186K
USRT icon
713
iShares Core US REIT ETF
USRT
$4.64B
$201K 0.01%
+3,267
New +$191K
IPWR icon
714
Ideal Power
IPWR
$67.2M
$188K ﹤0.01%
22,915
-2,700
-11% -$20.9K
LXFR icon
715
Luxfer Holdings
LXFR
$461M
$183K ﹤0.01%
+14,100
New +$164K
UNIT
716
Uniti Group
UNIT
$2.68B
$176K ﹤0.01%
31,249
-39,100
-56% -$167K
ULBI icon
717
Ultralife
ULBI
$89.6M
$173K ﹤0.01%
19,131
AGL icon
718
Agilon Health
AGL
$1.67B
$166K ﹤0.01%
1,694
-56
-3% -$7.23K
LXP icon
719
LXP Industrial Trust
LXP
$3.53B
$156K ﹤0.01%
3,109
COOK icon
720
Traeger
COOK
$189M
$151K ﹤0.01%
+819
New +$121K
DFTX
721
Definium Therapeutics
DFTX
$5.7B
$137K ﹤0.01%
24,100
INZY
722
DELISTED
Inozyme Pharma
INZY
$127K ﹤0.01%
24,300
ORGO icon
723
Organogenesis Holdings
ORGO
$313M
$123K ﹤0.01%
+42,913
New +$120K
IOVA icon
724
Iovance Biotherapeutics
IOVA
$2.29B
$119K ﹤0.01%
12,700
UROY
725
Uranium Royalty Corp
UROY
$454M
$119K ﹤0.01%
48,400
-35,449
-42% -$79.9K

Similar funds

Bailard's Q3 2024 Portfolio in Review

As of Q3 2024, Bailard held 836 positions worth $3.84B, up 5.8% from $3.63B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Bailard's Q3 2024 filing shows 114 new, 240 increased, 234 reduced and 102 closed positions. Its largest new stake was Vanguard Intermediate-Term Treasury ETF: 88,011 shares worth $5.32M. The largest sale was iShares MSCI EAFE ETF, an estimated $78.9M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Bailard's largest Q3 2024 buy was Vanguard Intermediate-Term Treasury ETF: 88,011 shares worth $5.32M.
  • Bailard added most to iShares Russell 2000 Value ETF in Q3 2024, an estimated $73.1M increase.
  • Bailard's biggest Q3 2024 reduction was iShares MSCI EAFE ETF, cutting an estimated $78.9M.
  • Bailard fully exited BorgWarner in Q3 2024, selling an estimated $4.11M.
  • Bailard's ten largest holdings make up 29% of its $3.84B portfolio in Q3 2024.
  • Bailard opened 114 new positions and closed 102 in Q3 2024.
  • Bailard's portfolio value rose 5.8% quarter-over-quarter to $3.84B.

Based on Bailard's 13F filing for Q3 2024, filed 30 Oct 2024.